Honest Comparison · June 2026
REMEVi vs. Eden
We compared pricing, features, bilingual support, and plan terms across both platforms. Here's exactly what we found — no spin.
Side-by-side
REMEVi vs. Eden feature by feature
Based on publicly available data, pricing pages, and patient reviews — June 2026.
| Feature | REMEVi | Eden |
|---|---|---|
| Semaglutide — lowest advertised | ✅ $199/mo (52-wk) · $279/mo monthly — all-inclusive | ~$209–229/mo ongoing ($129 first month, 3-mo plan) |
| Tirzepatide — lowest advertised | ✅ $269/mo (52-wk) · $379/mo monthly | ~$329/mo ongoing ($249 first month) |
| Lowest price requires long prepay? | ✅ No — monthly option, cancel anytime | ⚠️ Lowest needs 3-mo plan; $129 is first month only |
| Separate membership fee | ✅ None — care, meds & shipping bundled | ✅ None |
| Spanish-language support | ✅ Fully bilingual (built-in) | ❌ No Spanish support found (Jun 2026) |
| Bilingual care coordinator | ✅ Assigned to every patient | ❌ Not offered |
| LegitScript certified | ✅ Certified | ✅ Certified |
| All-inclusive price | ✅ Yes — one all-inclusive price | ✅ Yes |
Pricing and features subject to change. Eden's $129 is a first-month promotional rate on a 3-month plan, not the ongoing price. Always verify current pricing on each provider's website.
The bilingual difference
Built bilingual — not retrofitted
No Spanish-language support was found for Eden as of June 2026. REMEVi was built bilingual from the ground up. Every intake form, provider note, care coordinator message, and patient touchpoint is available in fluent English and Spanish.
GLP-1 programs
How the GLP-1 programs compare
Both REMEVi and Eden offer compounded semaglutide and tirzepatide for weight loss, prescribed by licensed US providers and prepared by state-licensed compounding pharmacies. What differs is the experience around the medication: how pricing is structured and advertised, care team access, language support, and response time.
On pricing: REMEVi's semaglutide is $199/month on the 52-week plan ($279/month month-to-month), and tirzepatide is $269/month on the 52-week plan ($379/month month-to-month) — all-inclusive. Eden advertises a $129 first-month rate on a 3-month semaglutide plan, but that is a first-month promotional price only; the ongoing rate runs approximately $209–229/month, and Eden's tirzepatide runs around $329/month ongoing ($249 first month). On the ongoing all-in number, REMEVi's semaglutide is competitive-to-lower and REMEVi's tirzepatide is lower. Always verify current pricing and plan terms directly on each provider's site.
On plan terms: REMEVi offers a true monthly option you can cancel anytime, with the lowest price available on the 52-week plan. Eden's lowest advertised number depends on committing to a 3-month plan and is a first-month-only teaser, not the price you keep paying. Read the fine print on what happens after month one.
On support: REMEVi assigns every patient a dedicated bilingual care coordinator with a 2-hour response target. For patients managing side effects, dosage questions, or medication concerns, response time matters significantly.
On language: This is where the platforms diverge. No Spanish-language support was found for Eden as of June 2026. REMEVi's entire platform — intake forms, clinical summaries, medication instructions, care coordinator communications — is available natively in English and Spanish. For the 62 million Spanish-speaking Americans, this is not a minor feature. It is a fundamental difference in the quality of care they receive.
FAQ
Common questions
Yes. REMEVi offers compounded semaglutide and tirzepatide prescribed by licensed US providers, with one transparent all-inclusive price covering clinical review, medication, shipping, and support. Where REMEVi stands apart is native bilingual English/Spanish care, a dedicated bilingual care coordinator for every patient, licensing across all 50 states plus DC, and a 2-hour response target. If you want pricing without a first-month-only teaser and Spanish-language support, REMEVi is a strong Eden alternative.
No. Eden's advertised $129 is a first-month promotional rate on a 3-month plan, not the ongoing monthly cost. After the first month, Eden's semaglutide runs approximately $209–229/month. Always verify the current ongoing price and plan terms directly on Eden's website, as telehealth pricing changes frequently and promotional terms vary.
It depends on the plan you compare. REMEVi's semaglutide is $199/month on the 52-week plan, which is competitive-to-lower versus Eden's ongoing rate of roughly $209–229/month. REMEVi's tirzepatide at $269/month on the 52-week plan is lower than Eden's ongoing rate of approximately $329/month. REMEVi's price is all-inclusive — clinical review, medication, shipping, and support. Compare the ongoing all-in number for your situation, not a first-month promotional headline, and verify current pricing on each provider's site.
No Spanish-language support was found for Eden as of June 2026. REMEVi is built natively bilingual — every intake form, care coordinator, and patient message is available in fluent English and Spanish from day one. Please verify current language support directly with each provider.
Yes — Eden markets an oral semaglutide option alongside injectable GLP-1 medications. REMEVi offers its own GLP-1 program, and a licensed provider determines the right medication and format for you based on your intake and clinical history. The best option depends on your individual situation, not the marketing.
Yes. Switching is straightforward — complete REMEVi's 5-minute intake form, a clinician reviews your case within 24 hours, and your medication ships within days. You do not need to formally cancel Eden before starting with REMEVi; simply time your transition to avoid overlapping charges. Compounded medications are non-FDA-approved preparations prepared by state-licensed compounding pharmacies and are not generic versions of, nor the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.
Compare REMEVi with other GLP-1 providers
See how REMEVi stacks up on price, bilingual support, and transparency.
Ready to get started with REMEVi?
Clinical review in 24 hours. No insurance needed. From $199/mo on 52-week plan, all-inclusive.
Start free consultation